# JETi Hong Kong Post Market Study (PMS)

> **NCT06340763** · — · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 12 (actual)

## Conditions studied

- Peripheral Venous Thrombosis
- Peripheral Arterial Thrombosis
- Peripheral Arteriovenous Thrombosis

## Interventions

- **DEVICE:** JETi Hydrodynamic Thrombectomy System

## Key facts

- **NCT ID:** NCT06340763
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-07
- **Primary completion:** 2025-02-12
- **Final completion:** 2025-02-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2025-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06340763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06340763, "JETi Hong Kong Post Market Study (PMS)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06340763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*